Condition

Unresectable

ClinicalTrials.gov condition label

Clinical trials2

Recruiting1

Common interventions7

Lead sponsors shown2

Clinical trials

2 shown

PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLCNCT06102057 · 2024-07-01

Durvalumab Alone or in Combination With Novel Agents in Subjects With NSCLCNCT03822351 · 2018-12-19

Common interventions

ChemotherapyDRUG1 DurvalumabDRUG1 Durvalumab + MonalizumabDRUG1 Durvalumab + OleclumabDRUG1 Experimental RadiotherapyRADIATION1 ImmunotherapyDRUG1 standard RadiotherapyRADIATION1

Leading sponsors

MedImmune LLC1 TheraOp1

Trial status mix

COMPLETED1

RECRUITING1

Phase mix

PHASE22

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.